Nanoveu Ltd. · ASX:NVU
Nanoveu — Shareholder Meeting (July 2020)
19 slides from Nanoveu's shareholder meeting presentation, Jul 29, 2020
Slide 1: AGM Presentation
For personal use only (ASX: NVU) AGM Presentation 27th July 2020
Slide 2: Year in Review
Year in Review For personal use only • Nanoveu completes transformational quarter with development, launch and first commercial distribution agreement of antiviral product • Antiviral product independently tested in Japan, Singapore and the US • Product successfully received TGA approval as a Class
Slide 3: Technology
Technology For personal use only Patent No. Territory Application No. Filing Date Earliest Priority Date Patent Application Title Patent Subject Matter Status Family PCT PCT/SG2013/000507 29-Nov-13 29-Nov-12 Expired IMR/P/07 Taiwan 102143854 29-Nov-13 29-Nov-12 Method Of Forming A Film Lenticular le
Slide 4: The New Normal
The New Normal For personal use only § Mobile phones are ubiquitous with millions of people around the world owning a device § All smartphones require touch to operate § Human contact and sharing phones can easily cause the spread of disease § Anti-bacterial covers are commonplace but unable to prev
Slide 5: The Problem
The Problem For personal use only § Currently +16 million documented cases of COVID-19 globally § Transmission of viruses such as COVID-19 can spread exponentially § Transmission rates significantly higher in affluent Western nations and spreading through the developing world § Strong awareness of n
Slide 6: The Solution
The Solution For personal use only § Independently tested in Japan, Singapore and the US § Registered as a Class 1 Medical Device with the TGA in Australia § Translucent screen capable of 90 percent visible light transparency with hardness of 2H & no wipes or refills required § Technology can extend
Slide 7: Products
For personal use only Products 7
Slide 8: Technology Validation
Technology Validation § Independent testing performed For personal use only § In 10 minutes 90% of the mouse-based coronavirus MHV-A59 was eradicated 1 § 99.99% of human coronavirus strain OC43 was eradicated in 30 minutes 1 o OC43 is a betacoronavirus. o Betacoronaviruses are single-stranded RNA vi
Slide 9: Virus Structure
Virus Structure B. Enveloped Virus with Spike Proteins A. Nonenveloped Virus For personal use only Membrane Capsid (Protein Coat) Nucleic Acid Spike proteins Viruses have a protective layer that attempts to preserve the infectious DNA/RNA inside long enough to infect host cells. Non-enveloped viruse
Slide 10: How it Works - Nanoparticles
How it Works - Nanoparticles For personal use only Bulk Material Increasing Nanoparticles Surface area Nanoshield infuses copper (cuprous) ion nanoparticles in the very top layer of film. Nanoparticles increase the active surface area, reducing self-disinfection time from 2+ hours (traditional coppe
Slide 11: How it Works
How it Works For personal use only Copper Ions Reactive Oxygen Species (ROS) Direct Contact Nanoshield produces electrically charged Nanoshield reacts with molecules that are produced by All viruses are surrounded by a protective protein layer copper ions that attach to viruses and bacteria bacteria
Slide 12: Pathway To Market
Pathway To Market For personal use only § Production: ü Mass manufacturing processes and supply chain management in place § Regulatory: ü TGA approval received as a Class I medical device v EPA/FDA/CE application underway § Sales and Marketing: v Launch of https://www.nanoshield.co/ v Number of B2B
Slide 13: Reference Sites
For personal use only Reference Sites 13
Slide 14: Applications
For personal use only Applications 14
Slide 15: Other Products
Other Products For personal use only Vending machine technology which Phone screen protector with ability precisely applies screen protectors to produce 3D graphics for the perfect fit 15
Slide 16: Products in Development
Products in Development For personal use only Anti-reflective screen protectors § Phone screen protector which eliminates § Anti-reflective coating is applied to hard PET cover which is adhered to a the need for reading glasses device § Addresses presbyopia § Enabling user to read their § Coating co
Slide 17: Corporate Snapshot
Corporate Snapshot Corporate details ASX price and volume July 2019 to July 2020 For personal use only Shares on issue 132.7m Options on issue 2.2m Market capitalisation ($0.076/share) $10.1m 52 week high - low $0.225 - $0.025 Major shareholders Board and management 32.8% Top 20 74.5% Board & manage
Slide 18: Disclosure and Disclaimer
Disclosure and Disclaimer The information in this presentation has been prepared by Nanoveu for the purposes of providing an overview of the company and its products. For personal use only This presentation does not constitute investment advice. Neither does this presentation nor the information con
Slide 19: Thank you
For personal use only Thank you Please contact: Alfred Chong [email protected] (+65-9008-0422) 19